Eversyn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 50.00 K
- Company Age 4 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
About Eversyn Laboratories
Eversyn Laboratories Private Limited (ELPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 January 2021 (Four years 9 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Merugu Kumar, Sree Mergu, Bharathi Kotha, and One other member serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U72900TG2021PTC147936
- Company No.
147936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Eversyn Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Merugu Kumar  | Director | 21-Jan-2021 | Current |
| Sree Mergu | Director | 28-Dec-2023 | Current |
| Bharathi Kotha | Director | 28-Dec-2023 | Current |
| Ramesh Varala | Director | 28-Dec-2023 | Current |
Financial Performance of Eversyn Laboratories.
Enhance accessibility to Eversyn Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eversyn Laboratories?
Unlock access to Eversyn Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sintilla Medcoms Private LimitedMerugu Kumar and Sree Mergu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eversyn Laboratories?
Eversyn Laboratories has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eversyn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eversyn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
